The Joseph Henry Press, an imprint of the National Academy Press, was created with the goal of making books on science, technology, and health more widely available to profes- sionals and the public.
Yarrowia lipolytica has emerged as a versatile yeast platform for biotechnological applications ranging from biofuel synthesis to high-value chemical production. Its oleaginous nature and robust ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Engineering biology is a tremendously powerful approach to finding sustainable alternatives to finite resources. However, it takes lots of time, money, and effort to develop the optimal microorganisms ...
Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...
In a small laboratory in Northbrook, Illinois, a team of scientists is trying to define the future of medicine. They aren't mixing chemicals in beakers or peering through microscopes. Instead, they ...
Biotechnology was born in South San Francisco in 1976. Since then, the Bay Area has become a hub for innovation and home to hundreds of biotechnology companies. To learn more about the biotech scene ...
HANGZHOU, China--(BUSINESS WIRE)--Qihan Biotech, a leader in applying multiplexable genome-editing technology to cell therapies and organ transplantation, today published research reporting the ...
Cutting-edge cellular engineering firm, MaxCyte, has developed a platform, which enables modifications to cells. Applications of MaxCyte's cellular engineering platform are far-reaching, such as ...
Karen Lucatero presents the Colombian Case Study at UNIDO Headquarters in Vienna in December 2019. Karen Lucatero's passion for helping people has taken her from a biotechnology engineering background ...
The agriculture biotechnology market, valued at an estimated USD 92.19 billion in 2025, is projected to reach USD 144.25 ...
Acute myeloid leukemia (AML) isn’t the most commonly known cancer. It is, however, one of the deadliest—an awful rare malignancy of the blood and bone marrow whose victims are already older and frail, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果